Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Mar 2014 01:28 PM
RNS
Director Declaration
20 Mar 2014 07:00 AM
RNS
Notification of Major Interest in Shares
19 Mar 2014 07:03 AM
RNS
New state of the art biomedical facility in UK
18 Mar 2014 02:46 PM
RNS
Update on the Acquisition of Evocutis plc
14 Mar 2014 07:00 AM
RNS
Placing to raise ?1 million & Notice of GM
13 Mar 2014 01:00 PM
RNS
Update of Evocutis plc acquisition
04 Mar 2014 07:00 AM
RNS
Acquisition
26 Feb 2014 07:00 AM
RNS
Acquisition of the trading assets of Evocutis PLC
13 Jan 2014 07:00 AM
RNS
Update re: Aquisition of German based CRO
16 Dec 2013 07:00 AM
RNS
Trading Update
09 Dec 2013 07:00 AM
RNS
Acquisition of Belfast Based CRO
29 Nov 2013 12:16 PM
RNS
Holding(s) in Company
31 Oct 2013 07:00 AM
RNS
Acquisition
11 Oct 2013 01:31 PM
RNS
Holding(s) in Company
03 Oct 2013 12:55 PM
RNS
Director's Dealing
02 Oct 2013 02:17 PM
RNS
Change of Registered Office
27 Sep 2013 07:00 AM
RNS
Interim Results
26 Sep 2013 07:00 AM
RNS
Half Yearly Report
28 Aug 2013 07:00 AM
RNS
Contract Win
23 Aug 2013 07:00 AM
RNS
Contract Win
23 Jul 2013 03:39 PM
RNS
Result of AGM
05 Jul 2013 07:00 AM
RNS
Notification of Major Interest in Shares
05 Jul 2013 07:00 AM
RNS
Notification of Major Interest in Shares
05 Jul 2013 07:00 AM
RNS
Notification of Major Interest in Shares
05 Jul 2013 07:00 AM
RNS
Notification of Major Interest in Shares
02 Jul 2013 01:22 PM
RNS
Result of General Meeting
02 Jul 2013 07:00 AM
RNS
Notification of Major Interest in Shares
01 Jul 2013 07:00 AM
RNS
Contract Win
01 Jul 2013 07:00 AM
RNS
Notification of Major Interest in Shares
26 Jun 2013 07:00 AM
RNS
Notification of Major Interest in Shares
14 Jun 2013 07:00 AM
RNS
Conditional Placing to raise ?25.5 million
13 Jun 2013 07:00 AM
RNS
Final Results
23 May 2013 07:00 AM
RNS
Result of AGM
17 May 2013 07:00 AM
RNS
Innovation division launch & co-development
07 May 2013 08:36 AM
RNS
Holding(s) in Company
26 Apr 2013 07:09 AM
RNS
Project wins
19 Apr 2013 12:00 PM
RNS
2012 Annual Report and Accounts
10 Apr 2013 07:00 AM
RNS
Audited 2012 Preliminary Results
09 Apr 2013 07:00 AM
RNS
Senior Management Appointments
27 Mar 2013 07:00 AM
RNS
Notification of Major Interest in Shares
14 Mar 2013 07:00 AM
RNS
Board Appointment
05 Mar 2013 01:19 PM
RNS
Holding(s) in Company
28 Feb 2013 12:47 PM
RNS
Director/PDMR Shareholding
21 Feb 2013 09:49 AM
RNS
Director/PDMR Shareholding
07 Feb 2013 07:00 AM
RNS
Venn Life Sciences expands into Russia
09 Jan 2013 07:00 AM
RNS
Notification of Major Interest in Shares
07 Jan 2013 07:00 AM
RNS
Contract Win
14 Dec 2012 07:00 AM
RNS
Admission to trading on AIM
12 Dec 2012 07:00 AM
RNS
Notification of Major Interest in Shares
12 Dec 2012 07:00 AM
RNS
Notification of Major Interest in Shares

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings